Table 2.
Serum levels of T3S, TT3, FT3, FT4 (mean and SD), and TSH (geometric mean and min-max values) in various groups throughout the study.
| Visits | V1 | V3a | V4 | V5 | |
|---|---|---|---|---|---|
| Study times (days) | 0 | 15 | 45 | 75 | |
| n | 36 | 36 | 34 | 34 | |
| T3S ng/dL | Group A | 8.68 (3.55) | 9.00 (3.55) | 8.51 (5.53) | 8.98 (4.48) |
| Group B | 10.55 (4.82) | 9.33 (3.34) | 13.63 (7.55) | 8.55 (3.16) | |
| Group C | 10.89 (5.65) | 7.59 (5.22) | 6.81 (4.76) | 10.04 (7.28) | |
| TT3 ng/dL | Group A | 116 (20.1) | 122 (11.4) | 110 (12.8) | 113 (11.5) |
| Group B | 108 (16.2) | 123 (49.9) | 111 (17.2) | 105 (17.8) | |
| Group C | 116 (15.1) | 108 (14.4) | 112 (20.4) | 112 (21.3) | |
| FT3 pg/mL | Group A | 3.61 (0.63) | 3.61 (0.61) | 3.23 (0.31) | 3.32 (0.57) |
| Group B | 3.32 (0.50) | 3.57 (0.48) | 3.50 (0.95) | 3.42 (0.48) | |
| Group C | 3.55 (0.40) | 3.64 (0.53) | 3.45 (0.32) | 3.37 (0.28) | |
| FT4 pg/mL | Group A | 12.05 (1.75) | 9.84 (1.33) | 8.97 (1.37) | 9.03 (1.52) |
| Group B | 11.35 (1.45) | 9.72 (1.02) | 9.21 (1.41) | 8.84 (1.14) | |
| Group C | 12.81 (2.05) | 11.58 (1.30) | 10.93 (1.37) | 10.83 (1.34) | |
| TSH μUI/mL | Group A | 0.382 (0.035–3.520) |
0.337 (0.670–2.170) |
0.734 (0.157–7.130) |
1.954 (0.580–12.700) |
| Group B | 0.362 (0.027–2.770) |
0.365 (0.085–1.550) |
0.875 (0.1167–3.370) |
1.526 (0.268–7.750) |
|
| Group C | 0.402 (0.018–1.160) |
0.500 (0.139–1.060) |
1.040 (0.244–2.500) |
1.050 (0.121–2.310) |